Literature DB >> 28667593

Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature.

Mohamed S AbdelBaki1, Steven G Waguespack2, Violeta Salceda3, Jeremy Jones4, Stacie L Stapleton5, David S Baskin6, M Fatih Okcu7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28667593     DOI： 10.1007/s11060-017-2554-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  6 in total

Review 1.  Clinical review: Pituitary carcinoma: difficult diagnosis and treatment.

Authors:  Anthony P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  Temozolomide: a novel treatment for pituitary carcinoma.

Authors:  Stephen Lim; Hrayr Shahinian; Menahem M Maya; William Yong; Anthony P Heaney
Journal:  Lancet Oncol       Date:  2006-06       Impact factor: 41.316

3.  Anti-VEGF therapy in pituitary carcinoma.

Authors:  Leon D Ortiz; Luis V Syro; Bernd W Scheithauer; Ayca Ersen; Humberto Uribe; Camilo E Fadul; Fabio Rotondo; Eva Horvath; Kalman Kovacs
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

4.  New targeted therapies in pituitary carcinoma resistant to temozolomide.

Authors:  Emmanuel Jouanneau; Anne Wierinckx; François Ducray; Véronique Favrel; Françoise Borson-Chazot; Jérôme Honnorat; Jacqueline Trouillas; Gérald Raverot
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

5.  Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.

Authors:  D Dworakowska; E Wlodek; C A Leontiou; S Igreja; M Cakir; M Teng; N Prodromou; M I Góth; S Grozinsky-Glasberg; M Gueorguiev; B Kola; M Korbonits; A B Grossman
Journal:  Endocr Relat Cancer       Date:  2009-07-20       Impact factor: 5.678

6.  Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.

Authors:  C J McCabe; K Boelaert; L A Tannahill; A P Heaney; A L Stratford; J S Khaira; S Hussain; M C Sheppard; J A Franklyn; N J L Gittoes
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958
  6 in total
  1 in total

1.  Pituitary carcinomas: Rare and challenging.

Authors:  Georges Sinclair; Martin Olsson; Hamza Benmakhlouf; Yahya Al-Saffar; Philippa Johnstone; Mustafa Aziz Hatiboglu; Alia Shamikh
Journal:  Surg Neurol Int       Date:  2019-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.